2021 Annual Conference - New Award Announcement
0 comments
by Thomas Willett
Dear members and friends of the Canadian Biomaterials Society, Announcing the CBS2021 Best Overall Presentation Award, sponsored by the Elsevier journal Biomaterials...
2021 Annual Conference - Second Call For Abstracts
0 comments
by Thomas Willett
Dear members and friends of the Canadian Biomaterials Society, The 36th Annual General Meeting will be held from May 13th to May 15th on Hopin, a virtual conference platform...
Bio & Nanomaterials in Tissue Engineering & Regene
0 comments
by Zhenwei Ma
Dear members of the Canadian Biomaterials Society, We are inviting you today to a Conference Series that is being organized by the BioEngineering and Therapeutic Solutions BEaTS Laboratory, in partnership with the Ottawa Student Chapter of the CBS CBS-OSC , the University of Ottawa, the University of Ottawa Heart Institute, and the University of Toronto...
2021 Annual Conference - Call For Abstracts
0 comments
by Thomas Willett
CALL FOR ABSTRACTS Dear members and friends of the Canadian Biomaterials Society, The 36th Annual General Meeting, hosted by the University of Waterloo, will be held from May 13th to May 15th on Hopin, a virtual conference platform...
Cardiovascular disease is the leading cause of mortality worldwide. In Canada, over 50 000 coronary artery bypass surgeries and percutaneous coronary interventions are performed each year...
Most cell therapy products require an ex vivo cell processing step in a polymeric culture device. The transition from open systems such as tissue culture polystyrene TCPS flasks to functionally closed systems such as cell culture bags often entails a change in materials in contact with cells...
Hemophilia is a bleeding disorder that affects roughly 1 in 5000 live births. A form of this disease, hemophilia B, is caused by deficiencies of the clotting protein, factor IX FIX , which is part of the coagulation cascade that, when activated by vascular injury, generates fibrin and its crosslinker, factor XIIIa FXIIIa ...
Arterial bypass graft is the primary therapy for patients with advanced vascular occlusion diseases and, in recent years, the development of tissue-engineered vascular grafts has emerged as a promising, clinically applicable alternative to autografts...
Bioactive glasses BGs are glasses with networks in either the silicate, borate, or phosphate systems, that form hydroxyl carbonate apatite HCA on the surface when introduced into a physiological environment...